Geneos Wealth Management’s First Trust Lunt US Factor Rotation ETF FCTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
303,333
-4,246
-1% -$164K 0.25% 91
2026
Q1
$11M Sell
307,579
-24,746
-7% -$910K 0.25% 91
2025
Q4
$11.9M Sell
332,325
-14,057
-4% -$498K 0.29% 80
2025
Q3
$12.3M Sell
346,382
-70,062
-17% -$2.41M 0.31% 75
2025
Q2
$14.2M Buy
416,444
+34,682
+9% +$1.11M 0.35% 70
2025
Q1
$11.8M Sell
381,762
-7,121
-2% -$234K 0.4% 53
2024
Q4
$12.8M Sell
388,883
-4,223
-1% -$139K 0.45% 41
2024
Q3
$12.2M Buy
393,106
+4,740
+1% +$143K 0.47% 43
2024
Q2
$12.1M Sell
388,366
-15,619
-4% -$480K 0.54% 38
2024
Q1
$12.6M Sell
403,985
-59,791
-13% -$1.74M 0.57% 32
2023
Q4
$12.9M Sell
463,776
-15,923
-3% -$403K 0.64% 32
2023
Q3
$11.8M Sell
479,699
-162,287
-25% -$4.21M 0.61% 31
2023
Q2
$16.9M Buy
641,986
+54,528
+9% +$1.4M 0.88% 15
2023
Q1
$16.1M Buy
587,458
+60,843
+12% +$1.7M 0.98% 14
2022
Q4
$14.7M Buy
526,615
+56,755
+12% +$1.61M 0.89% 17
2022
Q3
$12.3M Sell
469,860
-339,176
-42% -$9.65M 0.85% 19
2022
Q2
$22.2M Sell
809,036
-119,415
-13% -$3.54M 1.1% 14
2022
Q1
$30.4M Buy
928,451
+38,733
+4% +$1.24M 1.31% 9
2021
Q4
$31.6M Sell
889,718
-68,006
-7% -$2.4M 1.2% 10
2021
Q3
$32.7M Buy
957,724
+134,815
+16% +$4.77M 1.25% 9
2021
Q2
$28.9M Buy
822,909
+33,502
+4% +$1.15M 1.13% 14
2021
Q1
$26.9M Sell
789,407
-9,352
-1% -$301K 0.75% 28
2020
Q4
$26.4M Buy
798,759
+22,725
+3% +$625K 1.06% 15
2020
Q3
$19.3M Sell
776,034
-126,367
-14% -$3.15M 1% 15
2020
Q2
$20.8M Sell
902,401
-105,909
-11% -$2.25M 1.16% 12
2020
Q1
$17.8M Buy
1,008,310
+4,131
+0.4% +$87.1K 1.2% 13
2019
Q4
$22.9M Buy
1,004,179
+27,795
+3% +$616K 1.22% 10
2019
Q3
$21.1M Buy
976,384
+11,413
+1% +$250K 1.26% 11
2019
Q2
$20.9M Buy
964,971
+13,362
+1% +$285K 1.3% 10
2019
Q1
$19.9M Sell
951,609
-135,777
-12% -$2.68M 1.31% 9
2018
Q4
$19.1M Buy
1,087,386
+16,360
+2% +$312K 1.41% 8
2018
Q3
$22.2M Buy
+1,071,026
New +$21.9M 1.48% 6

Other funds holding FCTR

Geneos Wealth Management's FCTR Position: Q2 2026 in Review

Geneos Wealth Management reduced its First Trust Lunt US Factor Rotation ETF (FCTR) stake by 1.4% in Q2 2026, selling an estimated $164K and leaving 303,333 shares worth $12.4M. The position accounts for 0.25% of the portfolio, ranked #91.

Geneos Wealth Management first reported a position in FCTR in Q3 2018 and has held it in 32 quarters since. The position peaked at $32.7M in Q3 2021. 26 funds tracked by Wall St. Rank hold FCTR as of Q2 2026.

  • Geneos Wealth Management held 303,333 shares of First Trust Lunt US Factor Rotation ETF worth $12.4M as of Q2 2026.
  • Geneos Wealth Management sold 4,246 First Trust Lunt US Factor Rotation ETF shares in Q2 2026, an estimated $164K.
  • First Trust Lunt US Factor Rotation ETF made up 0.25% of Geneos Wealth Management's portfolio in Q2 2026, its #91 holding.
  • Geneos Wealth Management first reported a position in First Trust Lunt US Factor Rotation ETF in Q3 2018 and has held it in 32 quarters since.
  • Geneos Wealth Management's First Trust Lunt US Factor Rotation ETF position peaked at $32.7M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held First Trust Lunt US Factor Rotation ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.